Peripheral blood myeloid-derived suppressor cells reflect disease status in idiopathic pulmonary fibrosis

Fernandez Isis E., Greiffo Flavia R., Frankenberger Marion, Bandres Julia, Heinzelmann Katharina, Neurohr Claus, Hatz Rudolf, Hartl Dominik, Behr Jürgen, Eickelberg Oliver

Source: Eur Respir J 2016; 48: 1171-1183
Journal Issue: October
Disease area: Interstitial lung diseases

Congress or journal article abstractFull text journal articlePDF journal article, handout or slides

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
Fernandez Isis E., Greiffo Flavia R., Frankenberger Marion, Bandres Julia, Heinzelmann Katharina, Neurohr Claus, Hatz Rudolf, Hartl Dominik, Behr Jürgen, Eickelberg Oliver. Peripheral blood myeloid-derived suppressor cells reflect disease status in idiopathic pulmonary fibrosis. Eur Respir J 2016; 48: 1171-1183

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
Peripheral blood myeloid-derived suppressor cells reflect disease status in IPF
Source: ERS Lung Science Conference 2016
Year: 2016

LSC Abstract – Peripheral blood myeloid-derived suppressor cells reflect disease status in IPF
Source: International Congress 2016 – New therapies and therapeutic targets
Year: 2016

Upregulation of myeloid derived suppressor cells (MDSCs) in chronic obstructive pulmonary disease and its relationship with disease severity
Source: Annual Congress 2012 - Asthma and COPD: understanding through mechanisms
Year: 2012

Levels of CD4CD25 T regulatory cells in bronchial mucosa and peripheral blood of chronic obstructive pulmonary disease indicate involvement of autoimmunity mechanisms
Source: International Congress 2019 – Immunopathological mechanisms of lung disease
Year: 2019


Apoptosis and activation of peripheral blood neutrophils in chronic obstructive pulmonary disease
Source: Eur Respir J 2001; 18: Suppl. 33, 74s
Year: 2001

Increased regulatory T cells in the blood of patients with idiopathic pulmonary arterial hypertension
Source: Eur Respir J 2006; 28: Suppl. 50, 659s
Year: 2006

Pulmonary dendritic cells from chronic obstructive pulmonary disease patients suppress lung immune responses through induction of regulatory T cells
Source: Annual Congress 2011 - T-cell subsets
Year: 2011

Decreased mitochondrial complex I activity in blood lymphocytes of patients with idiopathic pulmonary fibrosis
Source: Virtual Congress 2020 – Translational aspects of idiopathic pulmonary fibrosis
Year: 2020


Peripheral blood Th17 and Th17/Th2 cells and their association with lung function and biomarkers in asthma-COPD overlap syndrome
Source: International Congress 2017 – Systemic and airway biomarkers
Year: 2017

Diminished peripheral T cell activity in sarcoidosis associates with progressive disease.
Source: International Congress 2018 – Granulomatous disorders: epidemiology, genotype and phenotype
Year: 2018



The role of regulator and effector T lymphocytes in chronic obstructive pulmonary disease and lung cancer
Source: Annual Congress 2010 - Pathology of lung cancer
Year: 2010

Expression of CD282+/CD284+ on blood granulocytes and its relationship to cytokine status in patients with stable chronic obstructive pulmonary disease
Source: Virtual Congress 2021 – Biomarkers to phenotype COPD: prediction of exacerbations
Year: 2021


Circulating monocytes from interstitial lung disease patients show an activated phenotype
Source: International Congress 2016 – ILD: from the bench to the bedside
Year: 2016

Cytokine releasing mucosa-homing T cells are increased in peripheral blood of pulmonary fibrosis patients
Source: Annual Congress 2010 - Pathogenesis of diffuse parenchymal lung disease
Year: 2010


¿Idiopathic pulmonary fibrosis or interstitial lung disease associated to connective tissue diseases? Endothelial progenitor cells as a potential tool for the differential diagnosis
Source: Virtual Congress 2020 – Physiological and cellular mechanisms affecting pulmonary pathologies
Year: 2020


Circulating tumor cells in chronic obstructive pulmonary disease patients
Source: Annual Congress 2011 - Innovative diagnostic methods for lung cancer
Year: 2011



Regulator and effector T lymphocytes in late stages of non small cell lung cancer and chronic obstructive pulmonary disease
Source: Annual Congress 2012 - New aspects of lung cancer biology
Year: 2012

Lung dendritic cells from chronic obstructive pulmonary disease patients induce type 1 T regulatory cells
Source: Annual Congress 2012 - Immunologic mechanisms in COPD and asthma
Year: 2012


Effect of ultrafine particle matter on human peripheral blood mononuclear cells of chronic obstructive pulmonary disease patients: involvement of the inflammasome.
Source: International Congress 2017 – From the bench: therapeutic approaches in COPD and emphysema
Year: 2017

Predicting prognosis of lung function decline in IPF using gene expression in peripheral blood mononuclear cells
Source: International Congress 2017 – Current molecular and genetic understanding of lung diseases
Year: 2017